Clinical trials recruiting for Hepatocellular Cancer
8
Recruiting trials
12
US states with sites
10
Countries
25%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Nivolumab | 2 |
| ABBV-324 | 1 |
| Alintegimod | 1 |
| Cisplatin | 1 |
| Durvalumab | 1 |
| Gemcitabine | 1 |
| Ipilimumab | 1 |
| Lenvatinib | 1 |
| MDX2001 | 1 |
| Nab-paclitaxel | 1 |
| Neoantigen Dendritic Cell Vaccine | 1 |
| Propranolol | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Missouri | 3 |
| Colorado | 2 |
| Florida | 2 |
| Tennessee | 2 |
| Texas | 2 |
| California | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| New Hampshire | 1 |
| New York | 1 |
| Pennsylvania | 1 |
| Rhode Island | 1 |
Top cities
Columbia, Missouri 2Houston, Texas 2Nashville, Tennessee 2Aurora, Colorado 1Boston, Massachusetts 1Chicago, Illinois 1Denver, Colorado 1Duarte, California 1Irvine, California 1Lake Mary, Florida 1
Self-screener
Recruiting trials
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
- Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
- Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
- Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
- Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Related conditions
Trials recruiting for Hepatocellular Cancer often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Colorectal cancer 1359Pancreatic cancer 870Non-small cell lung cancer 507Gastric cancer 91Esophageal cancer 65Renal Cancer 18Prostate cancer 1234Melanoma 487Hepatocellular carcinoma 51
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Hepatocellular Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.